2 months ago
MRUS
AnalystsBradley CaninoBradley Canino's Stock Forecasts
AnalystsBradley Canino
Sectors:
Analyst Ranking
Bottom 5%
#4334 out of 4552 analysts
Average Return
-10.38%
Win Rate
35%20 out of 57
Risk vs Reward
Poor
Good
Bradley Canino's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arvinas IncARVN | +102.60% | $16.51 | $33.45 | 2023-11-07 - 2024-04-17 | Strong Buy |
Merus NvMRUS | +100.73% | $20.45 | $41.05 | 2023-04-17 - 2024-04-17 | Strong Buy |
Merus NvMRUS | +94.55% | $21.10 | $41.05 | 2023-10-23 - 2024-04-17 | Strong Buy |
Merus NvMRUS | +78.79% | $22.96 | $41.05 | 2023-08-07 - 2024-04-17 | Strong Buy |
Alx Oncology Holdings IncALXO | +72.25% | $8.83 | $15.21 | 2023-11-13 - 2024-03-08 | Strong Buy |
Bradley Canino Analyst Color
Get additional color on Bradley Canino's coverage of popular stocks
4 months ago
CCCC
Bradley Canino's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Affimed NvAFMD | 5 | Hold | $5.00 | -4.40% | Maintains | 18 days ago |
Summit Therapeutics IncSMMT | 1 | Strong Buy | $8.00 | +124.09% | Initiates Coverage On | 24 days ago |
Alx Oncology Holdings IncALXO | 4 | Hold | $14.00 | -12.94% | Downgrades | a month ago |
Merus NvMRUS | 5 | Strong Buy | $65.00 | +58.34% | Maintains | 2 months ago |
Kymera Therapeutics IncKYMR | 4 | Strong Buy | $55.00 | +62.91% | Maintains | 2 months ago |
C4 Therapeutics IncCCCC | 3 | Strong Buy | $13.00 | +89.23% | Reiterates | 2 months ago |
Relay Therapeutics IncRLAY | 3 | Strong Buy | $30.00 | +383.09% | Maintains | 2 months ago |
Celcuity IncCELC | 1 | Strong Buy | $40.00 | +135.16% | Initiates Coverage On | 2 months ago |
Deciphera Pharmaceuticals IncDCPH | 6 | Strong Buy | $23.00 | +56.25% | Maintains | 2 months ago |
Blueprint Medicines CorpBPMC | 5 | Strong Buy | $97.00 | +9.75% | Maintains | 3 months ago |
Arvinas IncARVN | 4 | Strong Buy | $42.00 | +25.56% | Maintains | 5 months ago |
Zentalis Pharmaceuticals IncZNTL | 15 | Strong Buy | $36.00 | +183.24% | Maintains | 5 months ago |
Syndax Pharmaceuticals IncSNDX | 2 | Strong Buy | $36.00 | +73.58% | Maintains | 6 months ago |
Nuvalent IncNUVL | 1 | Strong Buy | $65.00 | +1.17% | Initiates Coverage On | 7 months ago |
Black Diamond Therapeutics IncBDTX | 4 | Strong Buy | $10.00 | +75.44% | Upgrades | 10 months ago |
Kura Oncology IncKURA | 2 | Strong Buy | $25.00 | +38.97% | Maintains | 10 months ago |
Theseus Pharmaceuticals IncTHRX | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | a year ago |
Turning Point Therapeutics IncTPTX | 2 | Hold | $45.00 | N/A | Maintains | 2 years ago |
Mersana Therapeutics IncMRSN | 1 | Hold | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Seagen IncSGEN | 1 | Hold | $145.00 | N/A | Initiates Coverage On | 3 years ago |
Zymeworks IncZYME | 1 | Buy | $55.00 | N/A | Initiates Coverage On | 3 years ago |
Epizyme IncEPZM | 1 | Buy | $13.00 | N/A | Initiates Coverage On | 3 years ago |
Exelixis IncEXEL | 1 | Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.